InvestorsHub Logo

TheHound

01/28/23 9:06 AM

#396062 RE: xoc #396059

“The early bird catches the worm. We better watch out or others will be the first to market a Peptide based antiinfective.”

Our bird is poolside stashing paychecks. In the CEO’s own words from Management’s Plan of Operation, page 27, most recent 10Q filing - link below for context:

“Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully.” - IPIX CEO

“In general, we expect to concentrate on product development and engage in a limited way in product discovery, avoiding the significant investment of time and financial resources that is generally required for a promising compound to be identified and brought into clinical trials.“ - IPIX CEO

https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany

https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793222008313/ipix_10q.htm